ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 2343

$2.61M Total Retail Price of All Prescriptions

Rank: 2 out of 2343

346 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 23,894 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

58% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

75 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 1,021 956 1 5
ATORVASTATIN CALCIUM 899 841 2 10
CRESTOR 671 604 3 30
ADVAIR DISKUS 605 495 4 34
EVISTA 601 525 5 128
CLOPIDOGREL 544 534 6 26
CELEBREX 507 446 7 71
OMEPRAZOLE 500 445 8 4
PRAVASTATIN SODIUM 483 409 9 15
NEXIUM 451 398 10 33
DIOVAN 428 417 11 23
METOPROLOL SUCCINATE 421 415 12 14
SINGULAIR 411 325 13 100
METFORMIN HCL 398 349 14 9
EXFORGE 381 368 15 163
LEVOCETIRIZINE DIHYDROCHLORIDE 363 321 10 16 223
PLAVIX 359 359 17 38
FAMOTIDINE 335 327 18 60
GLIMEPIRIDE 334 334 19 45
LIPITOR 330 326 20 78
PATANOL 311 288 21 310
AMMONIUM LACTATE 301 263 22 228
MONTELUKAST SODIUM 279 233 23 181
JANUVIA 275 273 24 50
PATADAY 275 259 24 392
VENTOLIN HFA 272 186 26 79
BISOPROLOL-HYDROCHLOROTHIAZIDE 264 227 27 151
BYSTOLIC 263 259 28 123
RANITIDINE HCL 247 206 29 43
LIDODERM 247 227 29 130
AVODART 245 232 31 165
TAMSULOSIN HCL 243 211 32 29
FLUTICASONE PROPIONATE 242 196 33 46
JANUMET 241 239 34 191
ACTOS 235 231 35 125
DEXILANT 227 212 36 184
LOVAZA 222 222 37 113
TRICOR 213 198 38 96
COREG CR 209 197 39 301
PANTOPRAZOLE SODIUM 207 189 40 22
LOSARTAN POTASSIUM 204 184 41 19
PROAIR HFA 200 174 42 86
TRILIPIX 200 185 42 214
SPIRIVA 199 199 44 48
MELOXICAM 184 141 45 68
LEVOTHYROXINE SODIUM 179 173 46 2
ALENDRONATE SODIUM 178 156 47 28
ATELVIA 177 176 48 234
NAMENDA 176 168 49 36
SYMBICORT 170 140 50 167
NASONEX 168 125 51 209
IBANDRONATE SODIUM 165 145 52 288
DONEPEZIL HCL 163 163 53 21
AZITHROMYCIN 163 144 53 39
INDAPAMIDE 151 141 55 170
FEXOFENADINE HCL 141 103 56 240
FENOFIBRATE 136 108 57 94
ZETIA 133 133 58 52
ALLOPURINOL 131 131 59 31
GABAPENTIN 129 115 60 16
MIRTAZAPINE 128 120 61 41
LOPERAMIDE 128 120 61 238
HYDROCORTISONE VALERATE 127 111 63 328
ONGLYZA 126 126 64 211
WELCHOL 122 121 65 233
BONIVA 116 110 66 332
ATENOLOL 111 101 67 12
POLYETHYLENE GLYCOL 3350 110 105 68 54
TRAMADOL HCL 107 107 69 25
SIMVASTATIN 102 95 70 1
PROCTOZONE-HC 99 88 71 208
CARVEDILOL 99 98 71 27
DILTIAZEM 24HR CD 98 90 73 83
DIOVAN HCT 98 88 73 63
VESICARE 96 86 75 145
CYMBALTA 95 79 76 74
SPIRONOLACTONE 91 91 77 65
EXELON 88 87 78 129
TRIAMCINOLONE ACETONIDE 87 82 79 137
COLCRYS 87 87 79 166
COMBIVENT 86 83 81 144
ACETAMINOPHEN-CODEINE 85 78 S3 82 112
ZOSTAVAX 84 66 83 236
PIOGLITAZONE HCL 84 80 R 83 347
RAMIPRIL 82 82 85 90
MUPIROCIN 82 69 85 260
ADACEL 81 65 87 384
FUROSEMIDE 80 80 88 6
BENICAR 80 76 88 93
GLIPIZIDE XL 78 77 90 84
AZOR 76 75 91 262
CHLORHEXIDINE GLUCONATE 75 75 92 219
CIPROFLOXACIN HCL 75 70 92 72
HYDROCODONE-ACETAMINOPHEN 74 74 S3 94 13
VOLTAREN 74 68 94 175
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 96 59
CALCIUM ACETATE 71 65 96 291
BETAMETHASONE DIPROPIONATE 70 70 98 284
LEVEMIR 70 70 98 250
PROLIA 69 68 100 519
NAPROXEN 69 66 100 108
ACTOPLUS MET 68 68 102 346
METOPROLOL TARTRATE 68 68 102 7
ALFUZOSIN HCL 68 68 102 523
VIREAD 67 67 105 426
LOSARTAN-HYDROCHLOROTHIAZIDE 66 66 106 64
ACTONEL 65 59 107 182
LACLOTION 64 56 108 531
VIMOVO 64 56 108 531
ISOSORBIDE MONONITRATE ER 62 62 110 32
VYTORIN 62 55 110 185
ESCITALOPRAM OXALATE 61 43 112 55
NATEGLINIDE 58 58 113 255
GLIPIZIDE ER 58 48 113 115
TEKTURNA 57 57 115 326
AGGRENOX 57 43 115 174
TEKTURNA HCT 55 55 117 558
CLONIDINE HCL 54 54 118 70
NIFEDIPINE ER 53 53 119 89
ROPINIROLE HCL 51 51 120 124
VERAPAMIL ER 51 34 120 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.